Welcome to LookChem.com Sign In|Join Free
  • or
Thieno[3,2-c]pyridine-2-methanamine, N-methyl- (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

709649-71-8

Post Buying Request

709649-71-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

709649-71-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 709649-71-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,0,9,6,4 and 9 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 709649-71:
(8*7)+(7*0)+(6*9)+(5*6)+(4*4)+(3*9)+(2*7)+(1*1)=198
198 % 10 = 8
So 709649-71-8 is a valid CAS Registry Number.

709649-71-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name N-methyl-1-(thieno[3,2-c]pyridin-2-yl)methanamine

1.2 Other means of identification

Product number -
Other names methylthieno[3,2-c]pyridin-2-ylmethylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:709649-71-8 SDS

709649-71-8Downstream Products

709649-71-8Relevant academic research and scientific papers

Rational design of novel CYP2A6 inhibitors

Tani, Niina,Juvonen, Risto O.,Raunio, Hannu,Fashe, Muluneh,Lepp?nen, Jukka,Zhao, Bin,Tyndale, Rachel F.,Rahnasto-Rilla, Minna

, p. 6655 - 6664 (2015/02/19)

Inhibition of CYP2A6-mediated nicotine metabolism can reduce cigarette smoking. We sought potent and selective CYP2A6 inhibitors to be used as leads for drugs useful in smoking reduction therapy, by evaluating CYP2A6 inhibitory effect of novel formyl, alk

HETEROCYCLIC COMPOUNDS, METHODS OF MAKING THEM AND THEIR USE IN THERAPY

-

Page 91, (2010/02/07)

In part, the present invention is directed to antibacterial compounds of formula (I) wherein A is a bicyclic heteroaryl ring or a tricyclic ring and R2 is an heterocyclic residue; L is a bond, or L is alkyl, alkenyl or cycloalkyl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 709649-71-8